Key Highlights
- Viz.ai and Cleerly partner to enhance heart disease detection and care coordination.
- Cleerly’s advanced AI software analyzes CCTA images for heart disease diagnosis.
- Viz.ai One platform integrates Cleerly’s technology, improving care for over 1,600 hospitals.
- Partnership streamlines diagnosis and speeds up specialist referrals for better patient outcomes.
Source: Business Wire
Notable Quotes
- “AI-powered automated detection of heart disease-associated ischemia will streamline diagnosis and facilitate timely specialist referrals, ultimately enhancing access to life-saving treatments and improving patient outcomes.” — Jonathan Aliota, MD, FACC, Interventional Cardiologist at Kelsey-Seybold Clinic
- “This partnership marks a significant step forward in our mission to revolutionize heart disease diagnostics and treatment, improving the detection of actionable heart health issues and transforming the landscape of cardiovascular care.” — James K. Min, MD, Founder and CEO at Cleerly
- “We are proud to partner with Cleerly to enhance our comprehensive AI platform, tailoring it to cardiovascular needs, enabling cardiologists and care teams to deliver optimal care to more patients most efficiently.” — Chris Mansi, MD, CEO and Co-founder at Viz.ai
SoHC's Take
This partnership between Viz.ai and Cleerly represents a major advancement in the field of cardiovascular care. By integrating Cleerly’s AI-driven diagnostics into the Viz.ai One platform, clinicians will benefit from faster, more accurate detection of heart disease, improving early intervention and personalized care plans. As heart disease remains the leading cause of death globally, such innovation is critical in enhancing both patient outcomes and the efficiency of healthcare delivery.
